2026/l 2027l Update)l Complexl Diagnosisl &l
Managementl inl Acutel Carel Practicuml
Review|l Q/Al |l Gradel A|l 100%l Correctl
(Verifiedl Answers)l -Chamberlain
Q:l Pressurel Ulcerl Stagingl isl usedl for:
Answer:
methodl ofl classifyingl pressurel ulcerl basedl onl depthl ofl tissuel destroyed
Q:l deepl tissuel injury
Answer:
Purplel orl maroonl localizedl areal ofl discoloredl intactl skinl orl blood-filledl blisterl duel tol
damagel ofl underlyingl softl tissuel froml pressurel and/orl shear.
Q:l Stagel 1l pressurel ulcer
Answer:
intactl skinl withl non-blanchablel rednessl ofl al localizedl area,l usuallyl overl al bonyl
prominence
Q:l stagel IIl pressurel ulcer
Answer:
Partiall thicknessl lossl ofl dermisl presentingl asl al shallowl openl ulcerl withl al redl pinkl
woundl bed,l withoutl slough.
Mayl alsol presentl asl anl intactl orl openl wound/rupturedl serum-filledl blister
,Q:l Stagel IIIl pressurel ulcer
Answer:
Fulll thicknessl tissuel loss.l Subcutaneousl fatl mayl bel visiblel butl bone,l tendonl orl musclel
arel notl exposed.
sloughl mayl bel presentl butl dosel notl obscurel thel depthl ofl tissuel loss.
MAYl includel underminingl andl tunneling
Q:l Stagel IVl pressurel ulcer
Answer:
Full-thicknessl tissuel lossl withl exposedl bone,l muscle,l orl tendon.
Sloughl orl escharl mayl bel presentl onl somel partsl ofl thel woundl bed.l OFTENl includesl
underminingl andl tunneling.
Q:l unstageable/unclassifiedl pressurel ulcer
Answer:
depthl unknown
fulll thicknessl (fulll skinl loss)
basel ofl ulcerl isl completelyl coveredl byl sloughl (yellow,l tan,l gray,l orl brown)l and/orl
escharl (tan,l brownl orl black)l inl woundl bed.
Q:l Differentialsl forl Osteomyelitis
Answer:
potentiall dxl r/tl bonel painl including:
Cellulitis
Diabeticl ulcer
Tuberculosisl bonel infection
Metastaticl cancer
,Q:l Appropriatel diagnosticl testingl inl osteomyelitis
Answer:
Bloodl culturesl (x2)
CBC
Baselinel erythrocytel sedimentationl ratel (ESR)l andl C-reactivel proteinl (CRP)
MRI
Bonel scan,l CT/PETl scan
Bonel biopsy
Additionall diagnosticl testing:l fungall bloodl cultures,l testingl forl Brucellal species,l andl
mycobacterium.
Q:l whatl arel ESRl &l CRPl usedl for?
Answer:
generall markersl ofl inflammationl andl arel usedl tol monitorl diseasel progressionl andl
resolution.
ESRl changesl slowly,l whilel CRPl changesl occurl morel rapidly.
CRPl mayl dropl withinl 1-2l weeksl ofl startingl therapy.
Q:l Whatl willl WBCl markersl willl includel whatl inl osteomyelitis?
Answer:
bandsl orl al leftl shift.
WBCl markersl ofl bacteriall infectionl includel anl increasel inl immaturel bandl neutrophilsl
"bands"l and/orl al "leftl shift".l
Al leftl shiftl indicatesl anl increasel inl neutrophill consumptionl equall tol anl increasel inl
production.l
Thesel markersl allowl al morel accuratel evaluationl ofl thel patient'sl condition.
Q:l Whatl isl thel mostl accuratel dxl imagingl forl osteomyelitis?
Answer:
MRI
, -X-rayl tol rulel outl al fracture.l
CTl scanl isl oftenl performedl tol detectl softl tissuel infectionl orl al foreignl body.l
-MRIl isl thel mostl accuratel imagingl testl tol detectl osteomyelitis.l -Inl casesl wherel MRIl isl
notl availablel orl contraindicated,l al bonel scanl orl PETl scanl mayl bel performed.
Q:l Whatl isl al bonel biopsyl usedl forl withl osteomyelitis?
Answer:
GOLDl STANDARDl
Bonel biopsyl isl thel goldl standardl forl detectingl thel causativel pathogenl orl forl
differentiatingl anl infectiousl causel froml al malignantl orl degenerativel process.
Q:l empiricl managementl ofl osteomyelitisl includes
(inpatient)
Answer:
beginl afterl collectingl cultures.
vancomycin-l forl gram-positivel coverage
AND
secondl drugl suchl asl cipro,l ceftazidimel orl cefepimel -activityl againstl Pseudomonasl &l
otherl gram-negativel bacili.
treatmentl usuallyl lastl 6l weeks
Q:l Whichl ofl thel followingl patientsl isl atl highestl riskl ofl osteomyelitis?
•32-year-oldl IVl drugl userl whol isl homeless.
•45-year-oldl schoolteacherl withl historyl renall transplant.
•72-year-oldl withl laboratoryl confirmedl influenza.
•22-year-oldl withl Crohn'sl disease.
Answer:
•32-year-oldl IVl drugl userl whol isl homeless.
•45-year-oldl schoolteacherl withl historyl renall transplant.